ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

DCBD Concepts Approved

November 8, 1985

In Brief: Kristian Storm Names Chief Of Surgical Oncology At Univ. Of Wisconsin; Skibba To Join CTEP

November 13, 1987

NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil.

November 2, 1990

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

ONS elects Officers, Presents Awards

June 4, 1993